Literature DB >> 7625613

Somatostatin and leu-enkephalin in the rat auditory brainstem during fetal and postnatal development.

M Kungel1, E Friauf.   

Abstract

A transient expression of the neuropeptide somatostatin has been described in several brain areas during early ontogeny and several opioid peptides, such as leu-enkephalin, have also been found in the brain at this stage in development. It is therefore believed that somatostatin and leu-enkephalin may play a role in neural maturation. The aim of the present study was to describe the spatiotemporal pattern of somatostatin and leu-enkephalin immunoreactivity in the auditory brainstem nuclei of the developing rat and to correlate it with other developmental events. In order to achieve this goal, we applied peroxidase-antiperoxidase immunocytochemistry to rat brains between embryonic day (E) 17 and adulthood. Somatostatin immunoreactivity (SIR) was found in all nuclei of the auditory brainstem, yet it was temporally restricted in most nuclei. SIR appeared prenatally and reached maximum levels around postnatal day (P) 7, when great numbers of immunoreactive neurons were present in the ventral cochlear nucleus (VCN) and in the lateral lemniscus. At that time relatively low numbers of cells were labeled in the dorsal cochlear nucleus, the lateral superior olive (LSO), and the inferior colliculus (IC). During the same period, when somata in the VCN were somatostatin-immunoreactive (SIR), a dense network of labeled fibers was also present in the LSO, the medial superior olive (MSO), and the medial nucleus of the trapezoid body (MNTB). As these nuclei receive direct input from VCN neurons, and as the distribution and morphology of the somatostatinergic fibers in the superior olivary complex (SOC) was like that of axons from VCN neurons, these findings suggest a transient somatostatinergic connection within the auditory system. Aside from the LSO, MSO, and MNTB, labeled fibers were found to a smaller extent in all other auditory brainstem nuclei. After P7, the SIR decreased and only a few immunoreactive elements were found in the adult auditory brainstem nuclei, indicating that somatostatin is transiently expressed in the rat auditory brainstem. Leu-enkephalin immunoreactivity showed a lower number and weaker intensity of labeled structures as compared to SIR, with E18 being the earliest day at which labeled fibers appeared in the SOC. At birth, immunoreactive fibers were also present in the cochlear nuclear complex and in the IC. Leu-enkephalin immunoreactive somata were found only after P12 in the CN and after P16 in the IC. Leu-enkephalin immunoreactivity was not transient, but increased progressively with age until about P21, when the adult levels were reached.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625613     DOI: 10.1007/bf00304428

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  87 in total

1.  Early transient expression of somatostatin (SRIF) immunoreactivity in dorsal root ganglia during ontogenesis in the rat.

Authors:  E Maubert; P Ciofi; G Tramu; M Mazzuca; J P Dupouy
Journal:  Brain Res       Date:  1992-02-21       Impact factor: 3.252

2.  The influence of inhibitory afferents on the development of postsynaptic dendritic arbors.

Authors:  D H Sanes; S Markowitz; J Bernstein; J Wardlow
Journal:  J Comp Neurol       Date:  1992-07-22       Impact factor: 3.215

3.  Analogues of somatostatin bind selectively to brain somatostatin receptor subtypes.

Authors:  K Raynor; D C Coy; T Reisine
Journal:  J Neurochem       Date:  1992-10       Impact factor: 5.372

4.  Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand.

Authors:  J McDowell; I Kitchen
Journal:  Eur J Pharmacol       Date:  1986-09-09       Impact factor: 4.432

5.  Somatostatin depresses excitability in neurons of the solitary tract complex through hyperpolarization and augmentation of IM, a non-inactivating voltage-dependent outward current blocked by muscarinic agonists.

Authors:  T Jacquin; J Champagnat; S Madamba; M Denavit-Saubié; G R Siggins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Effects of unilateral cochlea removal on anteroventral cochlear nucleus neurons in developing gerbils.

Authors:  G T Hashisaki; E W Rubel
Journal:  J Comp Neurol       Date:  1989-05-22       Impact factor: 3.215

7.  The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways.

Authors:  R E Hershberger; B L Newman; T Florio; J Bunzow; O Civelli; X J Li; M Forte; P J Stork
Journal:  Endocrinology       Date:  1994-03       Impact factor: 4.736

8.  Transient appearance of calbindin-D28k-positive neurons in the superior olivary complex of developing rats.

Authors:  E Friauf
Journal:  J Comp Neurol       Date:  1993-08-01       Impact factor: 3.215

9.  Endogenous opioid systems and the regulation of dendritic growth and spine formation.

Authors:  K F Hauser; P J McLaughlin; I S Zagon
Journal:  J Comp Neurol       Date:  1989-03-01       Impact factor: 3.215

10.  The immunocytochemical localization of enkephalin in the central nervous system of the rat.

Authors:  J C Finley; J L Maderdrut; P Petrusz
Journal:  J Comp Neurol       Date:  1981-06-01       Impact factor: 3.215

View more
  3 in total

1.  Receptive communication in late-stage Rett syndrome: a cautionary note.

Authors:  K A Meyer; C H Kennedy; S Shukla; L S Cushing
Journal:  J Autism Dev Disord       Date:  1999-02

2.  Comment on "Asperger syndrome: Familial, pre- and perinatal factors" by Gillberg and Cederland.

Authors:  Eileen Nicole Simon
Journal:  J Autism Dev Disord       Date:  2006-02

3.  Somatostatin in the pontine reticular formation modulates fear potentiation of the acoustic startle response: an anatomical, electrophysiological, and behavioral study.

Authors:  M Fendt; M Koch; H U Schnitzler
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.